Stem Cell Therapy in Autoimmune Diseases

Biomarkers, represented by genetically determined traits or biologic changes predictive of disease onset or outcome, are increasingly employed by academic and industrial investigators. They can identify unusually susceptible populations or individuals, facilitate prognosis, Currently, autoimmune conditions are treated with immune suppressive agents such as steroids, methothrexate, cyclosporine, gold, and more recently infliximab (Remicade). 
 

  • Hematopoietic Stem Cell Therapy for Autoimmune Diseases
  • Development of Hematopoietic Stem Cell Lines for Transplantation
  • Gene Therapy and Stem Cell Approaches for the Treatment of Autoimmune Diseases

Related Conference of Stem Cell Therapy in Autoimmune Diseases

June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
July 29-30, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
November 12-13, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
November 21-22, 2019

World Conference on Vaccine and Immunology

Dubai, UAE
November 25-26 , 2019

Global meet on Immunology and Molecular Biology

Paris, France
November 28-29, 2019

International Conference on Vaccines and Immune Response

Helsinki, Finland

Stem Cell Therapy in Autoimmune Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in